日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model.

在人源化小鼠模型中,NPRL2 基因疗法可诱导 KRAS/STK11 突变型抗 PD1 耐药转移性非小细胞肺癌 (NSCLC) 产生有效的抗肿瘤免疫

Meraz Ismail M, Majidi Mourad, Song Renduo, Meng Feng, Gao Lihui, Wang Qi, Wang Jing, Shpall Elizabeth J, Roth Jack A

SMARCA4 mutation induces tumor cell-intrinsic defects in enhancer landscape and resistance to immunotherapy

SMARCA4 突变导致肿瘤细胞增强子图谱出现内在缺陷,并产生免疫治疗耐药性。

Wang, Yawen; Meraz, Ismail M; Qudratullah, Md; Kotagiri, Sasikumar; Han, Yanyan; Xi, Yuanxin; Wang, Jing; Lissanu, Yonathan

Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

作者更正:3-磷酸肌醇依赖性激酶1驱动对奥希替尼的获得性耐药

Meraz, Ismail M; Majidi, Mourad; Fang, Bingliang; Meng, Feng; Gao, Lihui; Shao, RuPing; Song, Renduo; Li, Feng; Lissanu, Yonathan; Chen, Huiqin; Ha, Min Jin; Wang, Qi; Wang, Jing; Shpall, Elizabeth; Jung, Sung Yun; Haderk, Franziska; Gui, Philippe; Riess, Jonathan Wesley; Olivas, Victor; Bivona, Trever G; Roth, Jack A

An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses

一种改进的患者来源异种移植人源化小鼠模型用于评估肺癌免疫反应

Meraz, Ismail M; Majidi, Mourad; Meng, Feng; Shao, RuPing; Ha, Min Jin; Neri, Shinya; Fang, Bingliang; Lin, Steven H; Tinkey, Peggy T; Shpall, Elizabeth J; Morris, Jeffrey; Roth, Jack A

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

丝氨酸蛋白酶增强肺癌细胞上的免疫原性抗原呈递

Peters, Haley L; Tripathi, Satyendra C; Kerros, Celine; Katayama, Hiroyuki; Garber, Haven R; St John, Lisa S; Federico, Lorenzo; Meraz, Ismail M; Roth, Jack A; Sepesi, Boris; Majidi, Mourad; Ruisaard, Kathryn; Clise-Dwyer, Karen; Roszik, Jason; Gibbons, Don L; Heymach, John V; Swisher, Stephen G; Bernatchez, Chantale; Alatrash, Gheath; Hanash, Samir; Molldrem, Jeffrey J